AROMA: Assessment of the Aromatherapy to Alleviate Peri Operative Anxiety in Ambulatory Elective Upper Limb Surgery Under Loco-regional Anesthesia

Sponsor
University Hospital, Lille (Other)
Overall Status
Unknown status
CT.gov ID
NCT03583801
Collaborator
(none)
294
1
2
35.6
8.3

Study Details

Study Description

Brief Summary

AROMA study is a randomised controlled parallel-group single-site study. Patients randomized in the experimental group benefit from the aromatherapy at their arrival in the operating theatre in the recovery room. 2 drops of essential oils are applied on a compress placed next to the head of the patient. This compress is kept until the patient is leaving the operating theatre. Patients randomized in the control group don't benefit from the aromatherapy. The anxiety evolution is measured in both groups with the Amsterdam Preoperative Anxiety and Information Scale (APAIS). The hypothesis is that aromatherapy alleviate peri operative anxiety during an ambulatory elective upper limb surgery under loco-regional anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Other: Olfactory aromatherapy
  • Other: without aromatherapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
294 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Aromatherapy and Peri Operative Anxiety : Assessment in Ambulatory Elective Upper Limb Surgery Under Loco-regional Anesthesia, a Randomized Controlled Study
Actual Study Start Date :
Sep 14, 2018
Anticipated Primary Completion Date :
Sep 1, 2021
Anticipated Study Completion Date :
Sep 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: aromatherapy group

The patient has to choose an essential oil among the 3 proposed : sweet orange (Citrus sinensis L. Persoon) fine lavender (Lavandula angustifolia P. Miller) little seed from the mandarin tree (Citrus reticulata blanco)

Other: Olfactory aromatherapy
2 drops of the essential oil choosed by the patient are applied on a compress placed next to his head from his arrival in the recovery room to his leaving from the operating theatre. The method of administration is the respiratory tract..
Other Names:
  • Inhalation of essential oils
  • Placebo Comparator: without aromatherapy

    Other: without aromatherapy
    no intervention

    Outcome Measures

    Primary Outcome Measures

    1. Amsterdam Preoperative Anxiety and Information Scale (APAIS) score variation [Between time T0 (arrival in the operating room in the recovery room) and time T1 (10 minutes after T0, before loco-regional anesthesia), an average 10 minutes]

    Secondary Outcome Measures

    1. Anxiety Visual Analogic Scale change after the arrival in the operating room [at baseline and an average at 10 minutes,at 35 minutes, at 70 minutes and at 3 hours after arriving in operating room]

    2. Satisfaction Visual analogic Scale change after the arrival in the operating theater. [at baseline and an average ,at 35 minutes, at 70 minutes and at 3 hours after arriving in operating room]

    3. Comfort Visual analogic Scale variation change after the arrival in the operating theater. [at baseline and an average at 35 minutes, at 70 minutes and at 3 hours after arriving in operating room]

    4. Percentage of patients needing a perioperative drug-induced sedation. [at baseline and an average ,at 35 minutes, at 70 minutes and at 3 hours after arriving in operating room]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient admitted in Hospital Centre for an ambulatory elective upper limb " fast track " surgery

    • Patient with loco-regional anesthesia

    • Patient categorized 3 or less according to the American Society of Anesthesiologists (ASA) score

    • The patient must have given his written consent to participate in the study

    • Patient - insured under the French social security system

    • Patient prepared to comply with all the terms of the study and its length

    Exclusion Criteria:
    • Epileptic patients

    • Asthmatic patients

    • Patients with cognitive disorders ( Mini Mental Status below 15)

    • Psychiatric disorders : current depression or bipolar disease or anxiety disorders or psychotic disorders according to DSM-V classification

    • American Society of Anesthesiologists score strictly superior to 3

    • Preoperative chronic pain : neuropathic pain, fibromyalgia, polyarthritis

    • Pregnant or breastfeeding woman

    • Patient unable to receive an informed consent and to comply with all the terms of the study

    • Patient without any social insurance

    • Refusal to sign the consent

    • Patient under legal protection

    • Patient in emergency (unstable clinical state)

    • Patient unable to read or write french

    • Patient enrolled in an other clinical trial

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centre hospitalier Valenciennes France

    Sponsors and Collaborators

    • University Hospital, Lille

    Investigators

    • Principal Investigator: Cécile RIVOAL, University Hospital, Lille

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Lille
    ClinicalTrials.gov Identifier:
    NCT03583801
    Other Study ID Numbers:
    • 2017_58
    • 2018-A00642-53
    First Posted:
    Jul 11, 2018
    Last Update Posted:
    Aug 20, 2020
    Last Verified:
    Aug 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Lille
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 20, 2020